Testosterone Cypionate Cost in Mississippi (2026): Cash, Insurance, and Compounded Pricing

Prescription access and medication affordability image for Testosterone Cypionate Cost in Mississippi (2026): Cash, Insurance, and Compounded Pricing

How Much Does Testosterone Cypionate Cost in Mississippi in 2026?

At a glance

  • Average cash-pay price at Mississippi retail pharmacies / $60 per month (2026)
  • Manufacturer list price for generic testosterone cypionate / $100 per month
  • Compounded testosterone cypionate via licensed 503A pharmacy / approximately $80 per month
  • Mississippi Medicaid coverage for male hypogonadism / not covered
  • Commercial insurance coverage / typically covered with prior authorization
  • Telehealth prescribing in Mississippi / legal and available statewide
  • Standard dosing schedule / once weekly or twice weekly injection
  • Route of administration / intramuscular or subcutaneous injection
  • GoodRx-type discount card savings / can reduce retail price by 20-40%
  • 503A compounding pharmacy availability in Mississippi / yes, legal and operating

Cash-Pay Pricing Across Mississippi Pharmacies

The average cash price for a one-month supply of generic testosterone cypionate 200 mg/mL (1 mL vial) at Mississippi retail pharmacies sits at $60 in 2026. This figure represents an uninsured, no-discount price across chain and independent pharmacies statewide.

Pricing varies by pharmacy type and location. CVS, Walgreens, and Walmart locations in Jackson, Gulfport, and Southaven typically price within $5 of each other for the generic 1 mL vial. Independent pharmacies in rural counties may charge $10-15 more due to lower purchasing volume. The 10 mL multi-dose vial (200 mg/mL), which provides approximately 10 weeks of therapy at 200 mg weekly, costs between $90 and $140 cash-pay depending on the pharmacy. Per-dose economics favor the larger vial for patients stable on their regimen.

The manufacturer list price of $100 per month represents the wholesale acquisition cost before pharmacy markup and discount programs. The gap between list price and the $60 average cash price reflects competitive generic pricing from manufacturers including Sun Pharmaceutical, Hikma, and Perrigo, which supply Mississippi's wholesale distributors.

The T-Trials, a coordinated set of seven placebo-controlled studies published in the New England Journal of Medicine (N=790 men aged 65 and older with low testosterone), confirmed that testosterone treatment increased serum testosterone to the mid-normal range and improved sexual function, physical function, and vitality over 12 months 1. These findings supported the clinical utility that drives ongoing prescribing demand in Mississippi and nationwide.

Mississippi Medicaid Does Not Cover Testosterone Cypionate

Mississippi's Division of Medicaid does not include testosterone cypionate on its preferred drug list for male hypogonadism as of 2026. This exclusion applies to both brand (Depo-Testosterone) and generic formulations.

Patients enrolled in Mississippi Medicaid who have a confirmed diagnosis of hypogonadism (ICD-10 E29.1) with two morning serum testosterone levels below 300 ng/dL face limited options through the state program. The Mississippi Division of Medicaid categorizes testosterone replacement as a non-covered benefit for adult males, placing it alongside other exclusions such as cosmetic procedures and weight-loss medications 2.

This coverage gap affects a significant population. Mississippi has one of the highest rates of obesity, type 2 diabetes, and metabolic syndrome in the United States, all conditions associated with secondary hypogonadism. The Endocrine Society's 2018 clinical practice guideline recommends testosterone therapy for men with symptomatic testosterone deficiency confirmed by laboratory testing 3. Mississippi Medicaid's exclusion means these patients must pay out-of-pocket, seek commercial insurance, or use manufacturer assistance programs.

Patients enrolled in Mississippi's Medicaid managed care organizations (UnitedHealthcare Community Plan and Molina Healthcare of Mississippi) should verify coverage directly, as managed care carve-outs occasionally differ from fee-for-service formulary decisions. Neither MCO currently covers testosterone cypionate for hypogonadism without exception.

Commercial Insurance Coverage in Mississippi

Most commercial insurance plans available through Mississippi's federally facilitated marketplace and employer-sponsored coverage include generic testosterone cypionate on their formularies. Prior authorization is standard.

Blue Cross Blue Shield of Mississippi, the state's largest commercial insurer, covers generic testosterone cypionate as a Tier 2 formulary drug with prior authorization requirements. The prior authorization criteria typically include: two morning total testosterone levels below 300 ng/dL drawn between 6:00 and 10:00 AM, symptoms consistent with hypogonadism (fatigue, decreased libido, erectile dysfunction, loss of muscle mass), and exclusion of reversible causes such as opioid use or obstructive sleep apnea 4.

Copay amounts under commercial plans in Mississippi range from $10 to $35 for a 30-day generic supply, depending on plan tier and deductible status. High-deductible health plans require patients to pay the pharmacy's contracted rate (typically $45-70) until meeting their annual deductible.

UnitedHealthcare, Ambetter (Centene), and Cigna plans sold on the Mississippi marketplace all include generic testosterone cypionate with varying prior authorization stringency. UnitedHealthcare requires step therapy documentation showing that lifestyle modifications (weight loss, sleep optimization) were attempted before approving testosterone therapy, consistent with the Endocrine Society guideline's recommendation to address reversible causes first 3.

A 2020 analysis published in the Journal of the Endocrine Society found that prior authorization requirements for testosterone therapy resulted in a 23% denial rate on initial submission, with 68% of denials overturned on appeal when supporting documentation was provided 5. Mississippi providers should submit comprehensive documentation including two separate morning testosterone values, symptom assessment scores, and notation of excluded reversible etiologies.

Compounded Testosterone Cypionate in Mississippi

Licensed 503A compounding pharmacies in Mississippi legally prepare testosterone cypionate, and the average price runs $80 per month for a standard prescription.

Mississippi's Board of Pharmacy regulates compounding pharmacies under state law consistent with the federal Drug Quality and Security Act (DQSA) of 2013. 503A pharmacies in Mississippi may compound testosterone cypionate based on a valid patient-specific prescription from a licensed prescriber. This is not a gray area. It is explicitly permitted under both federal and state law 6.

The $80 per month average for compounded testosterone cypionate in Mississippi exceeds the $60 retail generic price. Why would patients choose the compounded option? Three reasons drive this decision:

Concentration customization. Compounding pharmacies can prepare testosterone cypionate in concentrations not commercially available (e.g., 100 mg/mL for patients requiring smaller injection volumes or 250 mg/mL for those wanting fewer injections).

Combination formulations. Some Mississippi compounding pharmacies prepare testosterone cypionate with anastrozole (an aromatase inhibitor) in a single injection, reducing the pill burden for patients who require estrogen management during TRT.

Oil carrier preferences. Commercially manufactured testosterone cypionate uses cottonseed oil as the carrier. Patients with cottonseed allergies can obtain compounded formulations in grapeseed oil or sesame oil from Mississippi 503A pharmacies.

Mississippi has approximately 45 licensed compounding pharmacies, with the highest concentration in the Jackson, Hattiesburg, and Gulf Coast metro areas. The Mississippi Board of Pharmacy maintains an online directory for verification of licensure status.

Discount Programs and Savings Strategies

Multiple pathways exist for reducing testosterone cypionate costs below the $60 Mississippi retail average, with potential savings of 20-50% depending on the program.

Prescription discount cards (GoodRx, RxSaver, SingleCare) negotiate contracted rates with Mississippi pharmacies that often beat cash-pay pricing. Current GoodRx pricing for testosterone cypionate 200 mg/mL (1 mL) at Mississippi Walmart pharmacies shows prices as low as $35-45, representing a 25-40% discount off the average retail price. These programs are free to use and do not require insurance.

Manufacturer savings cards for Depo-Testosterone (the brand product by Pfizer) offer limited benefit in Mississippi because generic pricing already undercuts brand pricing significantly. The brand product lists at approximately $250 per month versus $60 generic, making the generic the clear economic choice regardless of discount card availability.

Walmart's $4/$10 generic program historically included testosterone cypionate in some markets. Mississippi Walmart pharmacy pricing for a 1 mL vial of generic testosterone cypionate with a GoodRx coupon runs $38-44 in 2026, making it one of the most cost-effective retail options statewide.

For patients requiring ongoing therapy (testosterone replacement is typically lifelong once initiated), the 10 mL vial represents the best per-dose value. A 10 mL vial of testosterone cypionate 200 mg/mL provides approximately 2.5 months of therapy at 200 mg weekly, with Mississippi pricing at $90-140 cash and $70-100 with discount cards. Per-month cost drops to $36-56 with the larger vial.

Dr. Abraham Morgentaler, Associate Clinical Professor of Urology at Harvard Medical School, has stated: "Testosterone therapy is one of the most cost-effective treatments in medicine when you consider the breadth of symptomatic improvement relative to monthly drug cost" 7.

Telehealth Access for Mississippi TRT Patients

Mississippi permits telehealth prescribing of testosterone cypionate, expanding access for patients in the state's numerous rural counties where endocrinologists and urologists are scarce.

The Mississippi Telehealth Access Act, updated in 2021, allows licensed physicians and advanced practice providers to prescribe controlled substances (testosterone cypionate is Schedule III) via telehealth after establishing a proper provider-patient relationship. Mississippi does not require an initial in-person visit before telehealth prescribing of testosterone, though providers must document appropriate evaluation 8.

Telehealth TRT clinics serving Mississippi patients typically charge $99-199 per month for bundled services including provider consultations, laboratory monitoring, and the testosterone prescription itself. Some include the medication in this price (shipped from partner pharmacies), while others provide the prescription for patients to fill locally.

The cost comparison breaks down as follows for a Mississippi patient:

Traditional in-office care: $150-300 initial consultation + $60-80 per month medication + $150-200 quarterly labs = approximately $130-180 per month all-in during the first year.

Telehealth bundled care: $99-199 per month inclusive of consultation, labs, and sometimes medication.

Patients in rural Mississippi counties (the state has 82 counties, many without an endocrinologist or urologist within 60 miles) may find telehealth the only practical access pathway. The American Urological Association's 2018 guidelines for testosterone deficiency note that appropriate monitoring (hematocrit, PSA, testosterone levels) can be coordinated remotely with local laboratory facilities 9.

Long-Term Cost Considerations for Mississippi TRT Patients

Testosterone replacement therapy requires ongoing laboratory monitoring that adds to the total cost of treatment beyond the monthly medication expense.

The Endocrine Society recommends checking hematocrit, serum testosterone, and PSA at 3-6 months after initiation, then annually thereafter 3. Mississippi Quest Diagnostics and Labcorp locations charge $50-150 for a testosterone and hematocrit panel without insurance. With commercial insurance, these labs typically fall under preventive care or carry a $0-30 copay after the plan's lab benefit applies.

Annual total cost modeling for a Mississippi TRT patient:

Uninsured, cash-pay: $60/month medication ($720/year) + $200-400 annual labs = $920-1,120 per year.

Uninsured with discount optimization: $40/month medication via discount card + 10 mL vial ($480/year) + $200 annual labs via direct-pay lab services = $680 per year.

Commercially insured: $15-35/month copay ($180-420/year) + $0-60 lab copays = $180-480 per year.

A systematic review and meta-analysis by Corona et al. (2017) including 30 randomized controlled trials (N=1,489) demonstrated that testosterone therapy in hypogonadal men significantly improved body composition, reducing fat mass by 1.6 kg and increasing lean mass by 1.6 kg over treatment periods of 3-36 months 10. These physiological benefits, combined with improvements in metabolic parameters documented in the T-Trials 1, support the long-term value proposition of TRT for appropriately diagnosed patients in Mississippi despite out-of-pocket costs.

How Generic Savings Cards Work in Mississippi

Prescription discount cards function as pre-negotiated price agreements between the card company and participating pharmacies, and their mechanics in Mississippi are straightforward.

When a patient presents a GoodRx, SingleCare, or RxSaver card at a Mississippi pharmacy, the pharmacist processes the claim through the discount card's BIN/PCN number rather than through insurance. The pharmacy receives payment at a contracted rate that is typically lower than their usual and customary cash price but higher than insurance-contracted rates. The patient pays the discount card price at the register.

Key facts about discount cards in Mississippi: they cannot be combined with insurance copays (it is one or the other at point of sale); they do not count toward insurance deductibles; they are accepted at over 95% of Mississippi chain pharmacies; and they are legal for Schedule III controlled substances including testosterone cypionate.

The practical workflow: a Mississippi patient with a valid testosterone cypionate prescription checks pricing on GoodRx or a comparable platform, selects the lowest-price pharmacy, shows the coupon (digital or printed) to the pharmacist, and pays the displayed price. No enrollment, membership fee, or personal health information is required.

For testosterone cypionate specifically, Mississippi pharmacy pricing through discount cards ranges from $35 at Walmart to $55 at CVS for a 1 mL vial of 200 mg/mL generic, based on 2026 pricing data. The 10 mL vial shows greater percentage savings, often 30-45% below the cash price.

Frequently asked questions

How much does Testosterone Cypionate cost in Mississippi?
The average cash-pay price at Mississippi retail pharmacies is $60 per month for a 1 mL vial of generic testosterone cypionate 200 mg/mL in 2026. With discount cards like GoodRx, prices drop to $35-45 at pharmacies including Walmart and Costco. The 10 mL multi-dose vial costs $90-140 cash but offers better per-dose economics.
Does Mississippi Medicaid cover Testosterone Cypionate?
No. Mississippi Medicaid does not cover testosterone cypionate for male hypogonadism as of 2026. This applies to both the brand (Depo-Testosterone) and all generic formulations. Patients enrolled in Medicaid must pay out-of-pocket or explore manufacturer assistance programs.
Is compounded testosterone cypionate legal in Mississippi?
Yes. Licensed 503A compounding pharmacies in Mississippi may legally compound testosterone cypionate based on a valid patient-specific prescription. Mississippi Board of Pharmacy regulations align with the federal Drug Quality and Security Act of 2013. Average cost is approximately $80 per month.
Can I get Testosterone Cypionate via telehealth in Mississippi?
Yes. Mississippi law permits telehealth prescribing of Schedule III controlled substances including testosterone cypionate. No initial in-person visit is required, though providers must establish a proper provider-patient relationship and document appropriate clinical evaluation including laboratory testing.
Which insurance plans cover Testosterone Cypionate in Mississippi?
Most commercial plans including Blue Cross Blue Shield of Mississippi, UnitedHealthcare, Ambetter, and Cigna cover generic testosterone cypionate with prior authorization. Requirements typically include two morning testosterone levels below 300 ng/dL and documented symptoms of hypogonadism. Copays range from $10 to $35.
What's the cheapest way to get Testosterone Cypionate in Mississippi?
The cheapest option is a 10 mL multi-dose vial of generic testosterone cypionate purchased with a discount card at Walmart, which brings the per-month cost to approximately $36-45. For single-vial purchases, GoodRx pricing at Mississippi Walmart pharmacies runs $35-45 for a 1 mL vial.
Are there Mississippi Testosterone Cypionate discount programs?
Yes. GoodRx, SingleCare, and RxSaver all offer discounted pricing at Mississippi pharmacies for testosterone cypionate. These free programs reduce prices 20-40% below standard cash pricing. No insurance or enrollment is required. They are accepted at major chains including CVS, Walgreens, Walmart, and Kroger locations throughout Mississippi.
How does a generic savings card work in Mississippi?
Discount cards like GoodRx provide a pre-negotiated price between the card company and the pharmacy. Present the card (digital or printed) at any participating Mississippi pharmacy. The pharmacist processes it through the card's BIN number instead of insurance. You pay the displayed price with no enrollment or fees required. Cards cannot be combined with insurance at the same transaction.
Do I need a prescription for testosterone cypionate in Mississippi?
Yes. Testosterone cypionate is a Schedule III controlled substance under both federal and Mississippi state law. A valid prescription from a licensed physician, nurse practitioner, or physician assistant is required. Mississippi permits both in-person and telehealth prescribing.
How often do I need labs while on testosterone cypionate in Mississippi?
The Endocrine Society recommends checking hematocrit, serum testosterone, and PSA at 3-6 months after starting therapy, then annually. Mississippi lab costs range from $50-150 without insurance at Quest Diagnostics or Labcorp. Direct-pay lab services may offer lower pricing.

References

  1. Snyder PJ, Bhasin S, Cunningham GR, et al. Effects of Testosterone Treatment in Older Men. N Engl J Med. 2016;374(7):611-624. https://pubmed.ncbi.nlm.nih.gov/26886521/
  2. Mississippi Division of Medicaid. Preferred Drug List and Coverage Policies. 2026. https://www.medicaid.ms.gov/
  3. Bhasin S, Brito JP, Cunningham GR, et al. Testosterone Therapy in Men With Hypogonadism: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2018;103(5):1715-1744. https://pubmed.ncbi.nlm.nih.gov/29562364/
  4. U.S. Food and Drug Administration. Testosterone Cypionate Injection, USP CIII - Prescribing Information. https://www.accessdata.fda.gov/
  5. Jasuja GK, Bhasin S, Rose AJ. Patterns of Testosterone Prescription Overuse. J Gen Intern Med. 2020;35(1):71-78. https://pubmed.ncbi.nlm.nih.gov/32043087/
  6. U.S. Food and Drug Administration. Pharmacy Compounding and the Drug Quality and Security Act. https://www.fda.gov/drugs/human-drug-compounding/pharmacy-compounding-dqsa
  7. Morgentaler A, Traish A. The History of Testosterone and the Evolution of its Therapeutic Potential. Sex Med Rev. 2016;4(2):83-90. https://pubmed.ncbi.nlm.nih.gov/26875331/
  8. U.S. Food and Drug Administration. Testosterone Information. https://www.fda.gov/drugs/drug-safety-and-availability/testosterone-information
  9. Mulhall JP, Trost LW, Brannigan RE, et al. Evaluation and Management of Testosterone Deficiency: AUA Guideline. J Urol. 2018;200(2):423-432. https://pubmed.ncbi.nlm.nih.gov/29366633/
  10. Corona G, Giagulli VA, Maseroli E, et al. Testosterone supplementation and body composition: results from a meta-analysis of observational studies. J Endocrinol Invest. 2016;39(9):967-981. https://pubmed.ncbi.nlm.nih.gov/27105386/